EMEA-001071-PIP03-14-M01
Key facts
| Invented name |
Cimzia
|
| Active substance |
Certolizumab pegol
|
| Therapeutic area |
Dermatology
|
| Decision number |
P/0397/2018
|
| PIP number |
EMEA-001071-PIP03-14-M01
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of psoriasis
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
UCB Pharma S.A.
E-mail: ucbcares.uk@ucb.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|